Literature DB >> 30687535

The epidemiology of obstructive sleep apnoea and cardiovascular disease.

Paroma Sarkar1, Sutapa Mukherjee1,2, Ching Li Chai-Coetzer1,2, R Doug McEvoy2.   

Abstract

Obstructive sleep apnoea, the most common form of sleep-disordered breathing, is highly prevalent in patients with cardiovascular disease. The last 30 years has seen a plethora of large scale epidemiological studies investigating the relationship between sleep apnoea and cardiovascular outcomes. This review highlights the key epidemiological studies addressing the links between sleep apnoea and hypertension, cardiac arrhythmias, cerebrovascular disease, coronary artery disease, heart failure and pulmonary hypertension, with a particular focus on some of the most recent reports.

Entities:  

Keywords:  Epidemiology; cardiovascular; obstructive sleep apnoea (OSA)

Year:  2018        PMID: 30687535      PMCID: PMC6321894          DOI: 10.21037/jtd.2018.12.56

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  87 in total

Review 1.  Heart block in patients with sleep apnoea.

Authors:  H F Becker; U Koehler; A Stammnitz; J H Peter
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

2.  Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease.

Authors:  D Sajkov; T Wang; N A Saunders; A J Bune; A M Neill; R Douglas Mcevoy
Journal:  Am J Respir Crit Care Med       Date:  1999-05       Impact factor: 21.405

Review 3.  Obstructive sleep apnea and cardiovascular disease.

Authors:  Jo-Dee L Lattimore; David S Celermajer; Ian Wilcox
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

Review 4.  Risk factors for obstructive sleep apnea in adults.

Authors:  Terry Young; James Skatrud; Paul E Peppard
Journal:  JAMA       Date:  2004-04-28       Impact factor: 56.272

5.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

6.  Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study.

Authors:  F J Nieto; T B Young; B K Lind; E Shahar; J M Samet; S Redline; R B D'Agostino; A B Newman; M D Lebowitz; T G Pickering
Journal:  JAMA       Date:  2000-04-12       Impact factor: 56.272

7.  Prospective study of the association between sleep-disordered breathing and hypertension.

Authors:  P E Peppard; T Young; M Palta; J Skatrud
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

8.  Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study.

Authors:  P Lavie; P Herer; V Hoffstein
Journal:  BMJ       Date:  2000-02-19

9.  Association of hypertension and sleep-disordered breathing.

Authors:  E O Bixler; A N Vgontzas; H M Lin; T Ten Have; B E Leiby; A Vela-Bueno; A Kales
Journal:  Arch Intern Med       Date:  2000 Aug 14-28

10.  Echocardiographic features of the right heart in sleep-disordered breathing: the Framingham Heart Study.

Authors:  U C Guidry; L A Mendes; J C Evans; D Levy; G T O'Connor; M G Larson; D J Gottlieb; E J Benjamin
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

View more
  11 in total

1.  MRI evaluation of cerebrovascular reactivity in obstructive sleep apnea.

Authors:  Pei-Hsin Wu; Ana E Rodríguez-Soto; Zachary B Rodgers; Erin K Englund; Andrew Wiemken; Michael C Langham; John A Detre; Richard J Schwab; Wensheng Guo; Felix W Wehrli
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-15       Impact factor: 6.200

Review 2.  Impact of sleep apnea and treatments on cardiovascular disease.

Authors:  Andre Faria; Arthur Macedo; Carolina Castro; Elke Valle; Raquel Lacerda; Najib Ayas; Ismail Laher
Journal:  Sleep Sci       Date:  2022 Apr-Jun

Review 3.  Highlights of mechanisms and treatment of obesity-related hypertension.

Authors:  Elham Shams; Vijayvardhan Kamalumpundi; Joshua Peterson; Ronaldo Altenburg Gismondi; Wille Oigman; Marcelo Lima de Gusmão Correia
Journal:  J Hum Hypertens       Date:  2022-01-10       Impact factor: 2.877

Review 4.  Cardiovascular morbidities of obstructive sleep apnea and the role of circulating extracellular vesicles.

Authors:  Abdelnaby Khalyfa; Anabel L Castro-Grattoni; David Gozal
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

5.  Obstructive sleep apnea, hypertension, and obesity: A dangerous triad.

Authors:  Evgeny Belyavskiy; Elisabeth Pieske-Kraigher; Marijana Tadic
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-18       Impact factor: 3.738

6.  Influence of Intermittent Hypoxia/Hypercapnia on Atherosclerosis, Gut Microbiome, and Metabolome.

Authors:  Jin Xue; Celeste Allaband; Dan Zhou; Orit Poulsen; Cameron Martino; Lingjing Jiang; Anupriya Tripathi; Emmanuel Elijah; Pieter C Dorrestein; Rob Knight; Amir Zarrinpar; Gabriel G Haddad
Journal:  Front Physiol       Date:  2021-04-08       Impact factor: 4.755

7.  Interactions of central and autonomic nervous systems in patients with sleep apnea-hypopnea syndrome during sleep.

Authors:  Tingting Wang; Juan Yang; Yingjie Song; Feng Pang; Xinwen Guo; Yuxi Luo
Journal:  Sleep Breath       Date:  2021-07-07       Impact factor: 2.816

8.  Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea.

Authors:  José-Ramón Rueda; Iranzu Mugueta-Aguinaga; Jordi Vilaró; Mikel Rueda-Etxebarria
Journal:  Cochrane Database Syst Rev       Date:  2020-11-03

9.  Metoprolol prevents neuronal dendrite remodeling in a canine model of chronic obstructive sleep apnea.

Authors:  Lin Yang; Jing Zhao; Yang Qu; Qiang Sun; Ting-Ting Li; Mei-Ling Yan; Ming-Jing Duan; Ke-Xin Li; Yan-Ru Wang; Si-Yu Huang; Shuai Zhang; Yue Li; Jing Ai
Journal:  Acta Pharmacol Sin       Date:  2019-12-20       Impact factor: 6.150

10.  Endothelial dysfunction in obstructive sleep apnea patients.

Authors:  Michał Harańczyk; Małgorzata Konieczyńska; Wojciech Płazak
Journal:  Sleep Breath       Date:  2021-05-07       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.